Check out a new slide lecture, "Cardiac Amyloidosis Foundations," as part of ACC's free online course, Cardiac Amyloidosis: Accelerating Diagnosis and Treatment. Learn to identify symptomology of ...

The utility of left atrial appendage occlusion (LAAO) as a therapy for stroke prevention in patients with nonvalvular atrial fibrillation (AFib) is the focus of a State-of-the-Art Review published Jan ...

Whether you are a seasoned attendee or attending your first ACC Annual Scientific Session this year, don't miss the CV Team Section Town Hall, taking place ahead of ACC.25 on Wednesday, March 12 at ...

ACC's CV Team Section is offering travel awards for cardiovascular team members to attend ACC.25, taking place March 29-31, in Chicago, IL. Expenses including airfare, lodging, meals, and ground ...

A new collaboration between JACC and the U.S. Food and Drug Administration (FDA), will give cardiovascular clinicians a voice in shaping priorities for postmarket evidence generation in cardiovascular ...

The U.S. Food and Drug Administration (FDA) has issued a safety communication noting the potential need for early device replacement of Boston Scientific Corporation Accolade pacemaker devices.

The U.S. Food and Drug Administration (FDA) has approved the FARAPULSE Pulsed Field Ablation System for isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, ...

The focus of the Electrophysiology Section and Section Leadership Council is on the specialties of cardiac electrophysiology and electrocardiography and includes all aspects of management and ...

The Centers for Medicare and Medicaid Services (CMS) created two new G codes in the 2025 Medicare Physician Fee Schedule final rule that will provide reimbursement for atherosclerotic cardiovascular ...

Work, practice, expense and liability relative value units (RVUs) are updated annually through the Centers for Medicare and Medicaid Services' Medicare Physician Fee Schedule (PFS) rulemaking. In ...

Update as of August 2024: CMS issued additional instructions for reporting G2211 on Jan. 18 and posted an FAQ document in August 2024 that may be helpful in understanding proper use of G2211.

Stakeholders from cardiology, health systems, government and industry joined together to explore the challenges and evaluate potential solutions to integrating cardiovascular specialists into ...